{
    "nct_id": "NCT05130801",
    "official_title": "Phase I/IIa Study of Pre-operative Multiparametric MRI and pHLIPÂ® ICG Intra-operative Fluorescence Imaging of Primary Breast Cancer",
    "inclusion_criteria": "* Age 18 years or greater\n* Biopsy proven primary breast malignancy (BI-RADS 6)\n* Tumor stage Tis, T1 and T2, lesion size > 1 cm\n* Primary surgical treatment with breast conservation\n* No previous treatment\n* No contraindications for MRI or MRI contrast agents or high-field MRI (3T)\n* ECOG performance of 0-2\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Life expectancy < 3 months\n* Pregnancy or lactation\n* Known contrast agent allergies that require premedication before MRI.\n* Patients who cannot undergo multiparametric MRI scanning because of:\n\n  * Weight limits. MRI scanners may not be able to function with patients over 450 pounds.\n  * Severe claustrophobia/ examination associated anxiety.\n  * MRI unsafe implant\n* Known metastatic liver disease, hepatic neoplasms (benign and malignant), biliary atresia, chronic liver disease (CLD) and cirrhosis.\n* Known moderate hepatic impairment (in phase I, and in phase IIa dependent on safety profile established in phase I)\n* Known hypersensitivity to indocyanine green.\n* Individuals with impaired-decision making capacity",
    "miscellaneous_criteria": ""
}